These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22759194)

  • 21. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoclast-derived coupling factors in bone remodeling.
    Henriksen K; Karsdal MA; Martin TJ
    Calcif Tissue Int; 2014 Jan; 94(1):88-97. PubMed ID: 23700149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of Wnt signals in bone resorption during physiological and pathological states.
    Maeda K; Takahashi N; Kobayashi Y
    J Mol Med (Berl); 2013 Jan; 91(1):15-23. PubMed ID: 23111637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLIT2 inhibits osteoclastogenesis and bone resorption by suppression of Cdc42 activity.
    Park SJ; Lee JY; Lee SH; Koh JM; Kim BJ
    Biochem Biophys Res Commun; 2019 Jun; 514(3):868-874. PubMed ID: 31084928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of RANKL gene expression.
    O'Brien CA
    Bone; 2010 Apr; 46(4):911-9. PubMed ID: 19716455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.
    Jilka RL; O'Brien CA; Bartell SM; Weinstein RS; Manolagas SC
    J Bone Miner Res; 2010 Nov; 25(11):2427-37. PubMed ID: 20533302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. c-Src-Dependent and -Independent Functions of Matk in Osteoclasts and Osteoblasts.
    Kim JH; Kim K; Kim I; Seong S; Kim N
    J Immunol; 2018 Apr; 200(7):2455-2463. PubMed ID: 29440352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.
    Sheng MH; Wergedal JE; Mohan S; Amoui M; Baylink DJ; Lau KH
    PLoS One; 2012; 7(4):e35280. PubMed ID: 22536365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory mechanisms of osteoblast and osteoclast differentiation.
    Katagiri T; Takahashi N
    Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.
    Kitaura H; Marahleh A; Ohori F; Noguchi T; Shen WR; Qi J; Nara Y; Pramusita A; Kinjo R; Mizoguchi I
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The phytochemical plumbagin reciprocally modulates osteoblasts and osteoclasts.
    Yadav AM; Bagade MM; Ghumnani S; Raman S; Saha B; Kubatzky KF; Ashma R
    Biol Chem; 2022 Jan; 403(2):211-229. PubMed ID: 34882360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ROS signaling cascades: dual regulations for osteoclast and osteoblast.
    Tao H; Ge G; Liang X; Zhang W; Sun H; Li M; Geng D
    Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1055-1062. PubMed ID: 33085739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-range intercellular calcium signaling in bone.
    Jørgensen NR
    APMIS Suppl; 2005; (118):5-36. PubMed ID: 16279161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The matrix vesicle cargo miR-125b accumulates in the bone matrix, inhibiting bone resorption in mice.
    Minamizaki T; Nakao Y; Irie Y; Ahmed F; Itoh S; Sarmin N; Yoshioka H; Nobukiyo A; Fujimoto C; Niida S; Sotomaru Y; Tanimoto K; Kozai K; Sugiyama T; Bonnelye E; Takei Y; Yoshiko Y
    Commun Biol; 2020 Jan; 3(1):30. PubMed ID: 31949279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of FoxOs in Bone Health and Disease.
    Kim HN; Iyer S; Ring R; Almeida M
    Curr Top Dev Biol; 2018; 127():149-163. PubMed ID: 29433736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions.
    Levaot N; Simoncic PD; Dimitriou ID; Scotter A; La Rose J; Ng AH; Willett TL; Wang CJ; Janmohamed S; Grynpas M; Reichenberger E; Rottapel R
    J Clin Invest; 2011 Aug; 121(8):3244-57. PubMed ID: 21765218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.
    Pederson L; Ruan M; Westendorf JJ; Khosla S; Oursler MJ
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20764-9. PubMed ID: 19075223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of miR-125b in Osteoblasts Improves Age-Related Changes in Bone Mass and Quality through Suppression of Osteoclast Formation.
    Ito S; Minamizaki T; Kohno S; Sotomaru Y; Kitaura Y; Ohba S; Sugiyama T; Aubin JE; Tanimoto K; Yoshiko Y
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.